301258.SZ · 富士莱
China A-shares · RS rating 59 · As of 2026-10-14
| Price | 25.60 CNY |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 76 / 72 / 35 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 12 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.3% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $370.7M |